1. Home
  2. CPRX vs CEIX Comparison

CPRX vs CEIX Comparison

Compare CPRX & CEIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • CEIX
  • Stock Information
  • Founded
  • CPRX 2002
  • CEIX 1864
  • Country
  • CPRX United States
  • CEIX United States
  • Employees
  • CPRX N/A
  • CEIX N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • CEIX Coal Mining
  • Sector
  • CPRX Health Care
  • CEIX Energy
  • Exchange
  • CPRX Nasdaq
  • CEIX Nasdaq
  • Market Cap
  • CPRX 2.8B
  • CEIX 3.1B
  • IPO Year
  • CPRX 2006
  • CEIX 2017
  • Fundamental
  • Price
  • CPRX $20.60
  • CEIX $124.46
  • Analyst Decision
  • CPRX Strong Buy
  • CEIX Strong Buy
  • Analyst Count
  • CPRX 6
  • CEIX 1
  • Target Price
  • CPRX $30.50
  • CEIX $138.00
  • AVG Volume (30 Days)
  • CPRX 984.3K
  • CEIX 597.6K
  • Earning Date
  • CPRX 11-06-2024
  • CEIX 11-05-2024
  • Dividend Yield
  • CPRX N/A
  • CEIX 0.81%
  • EPS Growth
  • CPRX 114.68
  • CEIX N/A
  • EPS
  • CPRX 1.18
  • CEIX 13.65
  • Revenue
  • CPRX $460,482,000.00
  • CEIX $2,244,524,000.00
  • Revenue This Year
  • CPRX $21.99
  • CEIX N/A
  • Revenue Next Year
  • CPRX $17.95
  • CEIX $39.50
  • P/E Ratio
  • CPRX $17.48
  • CEIX $9.09
  • Revenue Growth
  • CPRX 32.17
  • CEIX N/A
  • 52 Week Low
  • CPRX $13.00
  • CEIX $75.43
  • 52 Week High
  • CPRX $24.27
  • CEIX $130.47
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 39.71
  • CEIX 67.14
  • Support Level
  • CPRX $21.30
  • CEIX $122.36
  • Resistance Level
  • CPRX $24.27
  • CEIX $130.47
  • Average True Range (ATR)
  • CPRX 0.79
  • CEIX 4.16
  • MACD
  • CPRX -0.18
  • CEIX 0.68
  • Stochastic Oscillator
  • CPRX 4.18
  • CEIX 77.75

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About CEIX CONSOL Energy Inc.

CONSOL Energy Inc is a producer and exporter of high-BTU bituminous coal. It owns and operates longwall mining operations in the nation and export terminals on the Eastern seaboard. The principal activity involves mining, preparation, and marketing of thermal coal, sold to power generators. Its operating segment includes PAMC (Pennsylvania Mining Complex) and CONSOL Marine Terminal. The company generates maximum revenue from the PAMC segment.

Share on Social Networks: